Eldad J Dann

11PUBLICATIONS
24CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseasesApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursAnimal production not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jul 14, 2026
Real-world outcomes of BrECADD therapy in advanced-stage classical Hodgkin lymphoma: A multicentre retrospective study.

|Feb 13, 2026
Platelet and Fibrinogen Dynamics After CAR-T Cell Therapy in Relapsed/Refractory B-Cell Lymphoma May Predict ICANS Onset.

Hazim Khatib, Amit Parizat, Jabour Halloun

|Dec 17, 2024
In COVID-19 Patients Supported with Extracorporeal Membrane Oxygenation, Intensive Care Unit Mortality Is Associated with the Blood Transfusion Rate.

Maged Makhoul, Eldad J Dann, Tatiana Mashiach

|Jun 19, 2024
Treatment Strategies in Advanced-Stage Hodgkin Lymphoma.

Eldad J Dann, René-Olivier Casasnovas

|Nov 14, 2023
The impact of CHOP versus bendamustine on bone mineral density in patients with indolent lymphoma enrolled in the GALLIUM study.

Mette Abildgaard Pedersen, Lars C Gormsen, Lasse H Jakobsen

|Feb 15, 2022
Reduction of the Vertebral Bone Mineral Density in Patients with Hodgkin Lymphoma Correlates with Their Age and the Treatment Regimen They Received.

Nadav Ofshenko, Eyal Bercovich, Tania Mashiach

Pageof 2

Frequent Collaborators

2 joint publications

Shimrit Ringelstein-Harlev

2 joint publications

Tsila Zuckerman

1 joint publications

Mette Abildgaard Pedersen

1 joint publications

Lars C Gormsen